Integrated Expression Profiles Analysis Reveals Correlations Between the IL-33/ST2 Axis and CD8(+) T Cells, Regulatory T Cells, and Myeloid-Derived Suppressor Cells in Soft Tissue Sarcoma.
Integrated Expression Profiles Analysis Reveals Correlations Between the IL-33/ST2 Axis and CD8(+) T Cells, Regulatory T Cells, and Myeloid-Derived Suppressor Cells in Soft Tissue Sarcoma.
复制标题
整合表达谱分析揭示软组织肉瘤中 IL-33/ST2 轴与 CD8( ) T 细胞、调节性 T 细胞和骨髓源性抑制细胞之间的相关性
DOI:
10.3389/fimmu.2018.01179
复制
发表时间:
2018
影响因子:
7.3
通讯作者:
Zheng F
中科院分区:
文献类型:
--
作者:
Chen H;Chen Y;Liu H;Que Y;Zhang X;Zheng F
Soft tissue sarcoma (STS) is a rare solid malignant cancer, and there are few effective treatment options for advanced disease. Cancer immunotherapy is a promising new strategy for STS treatment. IL-33 is a candidate cytokine for immunotherapy that can activate T lymphocytes and modulate antitumor immunity in some cancers. However, the expression and biological role of IL-33 in STS are poorly understood. In this study, we found that the expression of IL-33 and its receptor ST2 was decreased in STS using real-time PCR assays. By analyzing sarcoma data from The Cancer Genome Atlas, we found that higher transcriptional levels of IL-33 and ST2 were associated with a favorable outcome. There were positive correlations between the expression levels of ST2 and CD3E, CD4, CD8A, CD45RO, FOXP3, CD11B, CD33, and IFN-γ. Strong positive correlations between the expression of IFN-γ and CD3E and CD8A were also observed. Moreover, the expression levels of both IL-33 and ST2 were positively correlated with those of CD3E, CD8A, and chemokines that recruit CD8+ T cells, indicating that the IL-33/ST2 axis may play an important role in recruiting and promoting the immune response of type 1-polarized CD8+ T cells in STS. Meanwhile, we also found that the expression of IL-33 was negatively correlated with that of TGF-β1 and chemokines that recruit regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs), indicating that the IL-33/ST2 axis may also contribute to antagonizing Tregs, MDSCs, and TGF-β1-mediated immunosuppression in STS. The correlations between the IL-33/ST2 axis and CD8+ T cells and IFN-γ, as well as Tregs, MDSCs, and TGF-β1 were validated by additional analyses using three other independent GEO datasets of sarcoma. Our results implicate the possible role of the IL-33/ST2 axis in modulating antitumor immunity in STS. IL-33 may not only serve as a useful prognostic biomarker for STS but also as a potential therapeutic target for STS immunotherapy and worth further investigation.
登录
查看更多内容
影响因子:
--
作者:
Maki RG;Jungbluth AA;Gnjatic S;Schwartz GK;D'Adamo DR;Keohan ML;Wagner MJ;Scheu K;Chiu R;Ritter E;Kachel J;Lowy I;Old LJ;Ritter G
通讯作者:
Ritter G
影响因子:
7.2
作者:
Lucarini, Valeria;Ziccheddu, Giovanna;Schiavoni, Giovanna
通讯作者:
Schiavoni, Giovanna
DOI:
10.4049/jimmunol.1400481
发表时间:
2014-10-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Matta BM;Lott JM;Mathews LR;Liu Q;Rosborough BR;Blazar BR;Turnquist HR
通讯作者:
Turnquist HR
影响因子:
30.5
作者:
通讯作者:
--
影响因子:
9.7
作者:
Gao, Kun;Li, Xiaoying;Zhang, Lianfeng
通讯作者:
Zhang, Lianfeng